ENTERTAINMENT
More than 30 women come forward to accuse director James Toback of sexual harassment

Skin Cancer

UCLA’s effort to patent a costly prostate cancer drug in India hurts the poor, critics say

UCLA’s effort to patent a costly prostate cancer drug in India hurts the poor, critics say

After scientists at UCLA created a breakthrough treatment for prostate cancer, it generated more than half a billion dollars for the university.

But deals struck with drugmakers also obligated university officials to help pursue patent protection for the drug around the world. Now, consumer activists claim that UCLA’s efforts are propping up the drug’s high prices — which can top $130,000 a year for a cancer patient in the U.S. — and keeping poor patients in less-developed nations from getting cheaper versions.

The university holds the patent on the chemical compounds its researchers developed that were used to create the drug called enzalutamide, which is sold under the...

EDITION: California | U.S. & World
65°